Coexpression of Activated c-Met and Death Receptor 5 Predicts Better Survival in Colorectal Carcinoma-Reference-Cited by-同舟云学术

Coexpression of Activated c-Met and Death Receptor 5 Predicts Better Survival in Colorectal Carcinoma

Published:2011-12 Issue:6 Volume:179 Page:3032-3044
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Uddin Shahab,Hussain Azhar R.,Ahmed Maqbool,Al-Sanea Nasser,Abduljabbar Alaa,Ashari Luai H.,Alhomoud Samar,Al-Dayel Fouad,Bavi Prashant,Al-Kuraya Khawla S.

Funder

National Comprehensive Plan for Science and Technology

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference47 articles.

1. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial;Douillard;Lancet,2000

2. Beyond 5-fluorouracil: new horizons in systemic therapy for advanced colorectal cancer;Khamly;Expert Opin Investig Drugs,2005

3. Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer;Hurwitz;J Clin Oncol,2005

4. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer;Cunningham;N Engl J Med,2004

5. Systemic therapy for colorectal cancer;Meyerhardt;N Engl J Med,2005

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Down-Regulation of Death Receptor-5 in Metastatic Cascade of Triple-Negative Breast Cancer;Turkish Journal of Oncology;2020

2. Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells;BMC Cancer;2019-05-24

3. Role of animal research in human malignancies;Animal Models in Cancer Drug Discovery;2019

4. Understanding and Targeting MET Signaling in Solid Tumors - Are We There Yet?;Journal of Cancer;2016

5. Suppression of death receptor 5 enhances cancer cell invasion and metastasis through activation of caspase-8/TRAF2-mediated signaling;Oncotarget;2015-10-15